Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q4 EPS of ($0.19), $0.03 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.